Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile
- 1 March 1999
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 30 (3), 376-382
- https://doi.org/10.1016/s0168-8278(99)80093-2
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Differential effect of IFN alpha-2b and ribavirin on the HCV-RNA level in primary cultures of human hepatocytes derived from chronic HCV carriers and of human hepatocytes infected in vitroJournal of Hepatology, 1998
- Ribavirin Inhibits Viral-Induced Macrophage Production of TNF, IL-1, the Procoagulant fgl2 Prothrombinase and Preserves Th1 Cytokine Production But Inhibits Th2 Cytokine ResponseThe Journal of Immunology, 1998
- Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis CThe Lancet, 1998
- Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled studyJournal of Hepatology, 1996
- The expanding universe of T-cell subsets: Th1, Th2 and moreImmunology Today, 1996
- Aerosolized Ribavirin Treatment of Infants with Respiratory Syncytial Viral InfectionNew England Journal of Medicine, 1983
- Selective inhibition of functional lymphocyte subpopulations by ribavirinAntimicrobial Agents and Chemotherapy, 1982